Regeneron Pharmaceuticals
S&P 500
Nasdaq 100
$781.49
-1.48%
Delayed · cached 15 min
Frequently asked questions
What sector does Regeneron Pharmaceuticals belong to?
Regeneron Pharmaceuticals operates in the Health Care sector, specifically the Biotechnology industry, and is listed on the US markets.
What is the current share price of REGN?
As of the latest available quote, REGN traded at $781.49. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of REGN?
Regeneron Pharmaceuticals has a price-to-earnings (P/E) ratio of about 19.34. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of REGN?
The market capitalisation of Regeneron Pharmaceuticals is approximately $84.87B.
Is Regeneron Pharmaceuticals profitable?
For its latest reported financial year, Regeneron Pharmaceuticals recorded a net profit margin of about 31.41%.
Does REGN pay a dividend?
Regeneron Pharmaceuticals currently has a dividend yield of about 0.46%.
What is the return on equity (ROE) of REGN?
Regeneron Pharmaceuticals has a return on equity (ROE) of about 14.21%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of REGN?
Over the past 52 weeks, REGN has traded between a low of $541.00 and a high of $859.34.
These answers are generated from reported financial data and live market figures, for educational and informational purposes only.